Skip to main content
Clinical Trials/NCT02953288
NCT02953288
Unknown
Not Applicable

Differential Diagnosis and Clinical Treatment Strategies of Thyroid Nodules.

Shanghai 10th People's Hospital1 site in 1 country3,000 target enrollmentOctober 2016
ConditionsThyroid Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Thyroid Cancer
Sponsor
Shanghai 10th People's Hospital
Enrollment
3000
Locations
1
Primary Endpoint
Gene sequencing
Last Updated
9 years ago

Overview

Brief Summary

To investigate the genetic mutations of patients with thyroid carcinoma and find molecular targets for therapy.

Detailed Description

In previous studies, we have found highly prevalent TERT promoter mutations in aggressive thyroid cancers. So we plan to perform further research to investigate the genetic mutations of patients with thyroid carcinoma and find molecular targets for therapy.

Registry
clinicaltrials.gov
Start Date
October 2016
End Date
December 2018
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Shanghai 10th People's Hospital
Responsible Party
Principal Investigator
Principal Investigator

Zhang Manna

Department of Endocrinology

Shanghai 10th People's Hospital

Eligibility Criteria

Inclusion Criteria

  • Patient with thyroid nodule

Exclusion Criteria

  • Coagulant function abnormality

Outcomes

Primary Outcomes

Gene sequencing

Time Frame: 2 weeks

Study Sites (1)

Loading locations...

Similar Trials